ZA966837B - Derivatives of 5-0-desosaminyl 6-0-methyl erythronolide A, their preparation process and their use for the preparation of biologically-active products. - Google Patents

Derivatives of 5-0-desosaminyl 6-0-methyl erythronolide A, their preparation process and their use for the preparation of biologically-active products.

Info

Publication number
ZA966837B
ZA966837B ZA9606837A ZA966837A ZA966837B ZA 966837 B ZA966837 B ZA 966837B ZA 9606837 A ZA9606837 A ZA 9606837A ZA 966837 A ZA966837 A ZA 966837A ZA 966837 B ZA966837 B ZA 966837B
Authority
ZA
South Africa
Prior art keywords
preparation
desosaminyl
biologically
derivatives
active products
Prior art date
Application number
ZA9606837A
Other languages
English (en)
Inventor
Alain Bonnet
Michel Delthil
Alain Mazurie
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA966837(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA966837B publication Critical patent/ZA966837B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9606837A 1995-09-11 1996-08-13 Derivatives of 5-0-desosaminyl 6-0-methyl erythronolide A, their preparation process and their use for the preparation of biologically-active products. ZA966837B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510601A FR2738571B1 (fr) 1995-09-11 1995-09-11 Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs

Publications (1)

Publication Number Publication Date
ZA966837B true ZA966837B (en) 1997-08-13

Family

ID=9482423

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606837A ZA966837B (en) 1995-09-11 1996-08-13 Derivatives of 5-0-desosaminyl 6-0-methyl erythronolide A, their preparation process and their use for the preparation of biologically-active products.

Country Status (34)

Country Link
US (1) US5969161A (no)
EP (1) EP0854880B1 (no)
JP (1) JP4332218B2 (no)
KR (1) KR100457755B1 (no)
CN (2) CN1237069C (no)
AP (1) AP887A (no)
AR (1) AR004195A1 (no)
AT (1) ATE266035T1 (no)
AU (1) AU708811B2 (no)
BG (1) BG63822B1 (no)
BR (1) BR9610503A (no)
CA (1) CA2228670C (no)
CZ (3) CZ294866B6 (no)
DE (1) DE69632405T2 (no)
DK (1) DK0854880T3 (no)
EA (1) EA000575B1 (no)
EE (1) EE03774B1 (no)
ES (1) ES2219698T3 (no)
FR (1) FR2738571B1 (no)
GE (1) GEP20022838B (no)
HK (2) HK1016187A1 (no)
HU (1) HU227565B1 (no)
IL (1) IL123550A (no)
MX (1) MX9801859A (no)
NO (2) NO312678B1 (no)
PL (1) PL183652B1 (no)
PT (1) PT854880E (no)
RO (1) RO120137B1 (no)
SI (1) SI0854880T1 (no)
SK (3) SK285853B6 (no)
TR (1) TR199800438T1 (no)
UA (1) UA53628C2 (no)
WO (1) WO1997010251A1 (no)
ZA (1) ZA966837B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
ATE296832T1 (de) * 1996-09-04 2005-06-15 Abbott Lab 6-o-substituierte ketoliden mit antibakteriellen wirkung
US6034069A (en) * 1997-09-30 2000-03-07 Abbott Laboratories 3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
US6124269A (en) * 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
US6046171A (en) * 1997-10-29 2000-04-04 Abbott Laboratories 6,11-bridged erythromycin derivatives
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6420535B1 (en) 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
NZ535354A (en) * 2002-02-15 2008-01-31 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
WO2005070918A1 (en) * 2002-05-13 2005-08-04 Enanta Pharmaceuticals, Inc. Process for the preparation of t-11 bicyclic erythromycin derivatives
NZ536402A (en) * 2002-05-13 2006-08-31 Enanta Pharm Inc 6,11 bicyclic erythromycin derivatives
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7064110B2 (en) * 2002-05-13 2006-06-20 Enanta Pharmaceuticals, Inc. 6-11 bicycle ketolide derivatives
US7135573B2 (en) * 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7273853B2 (en) * 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6878691B2 (en) * 2002-05-13 2005-04-12 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005067564A2 (en) * 2004-01-07 2005-07-28 Enanta Pharmaceuticals, Inc. 6-11 bicyclic erythromycin derivatives
US7265094B2 (en) * 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
US7229972B2 (en) 2004-12-07 2007-06-12 Enanta Pharmaceuticals, Inc. 3,6-Bicyclolides
US7419962B2 (en) 2004-12-07 2008-09-02 Enanta Pharmaceuticals, Inc. 3,6-bicyclolides
WO2006065721A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. 11, 12-lactone bicyclolides
WO2006065743A2 (en) 2004-12-13 2006-06-22 Enanta Pharmaceuticals, Inc. Tetracylic bicyclolides
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
AU2006274197A1 (en) * 2005-07-26 2007-02-01 Merckle Gmbh Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase
NZ600635A (en) * 2007-09-17 2013-06-28 Enanta Pharm Inc 6, 11-bridged biaryl macrolides
US8354383B2 (en) * 2007-09-17 2013-01-15 Enanta Pharmaceuticals, Inc. 6,11-bridged biaryl macrolides
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
CN103232501A (zh) * 2013-04-11 2013-08-07 宜昌东阳光药业股份有限公司 阿奇霉素或阿奇霉素的中间体脱去克拉定糖化合物的制备工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives

Also Published As

Publication number Publication date
FR2738571A1 (fr) 1997-03-14
CN1070498C (zh) 2001-09-05
HUP9802930A3 (en) 1999-12-28
NO20021111L (no) 1998-03-10
JPH11512416A (ja) 1999-10-26
EA199800288A1 (ru) 1998-08-27
AP887A (en) 2000-11-10
IL123550A (en) 2002-09-12
PT854880E (pt) 2004-09-30
FR2738571B1 (fr) 1997-10-17
JP4332218B2 (ja) 2009-09-16
NO981053L (no) 1998-03-10
NO315048B1 (no) 2003-06-30
EP0854880A1 (fr) 1998-07-29
DK0854880T3 (da) 2004-08-16
EE03774B1 (et) 2002-06-17
SK283690B6 (sk) 2003-12-02
BR9610503A (pt) 1999-07-06
RO120137B1 (ro) 2005-09-30
AU708811B2 (en) 1999-08-12
EP0854880B1 (fr) 2004-05-06
GEP20022838B (en) 2002-11-25
CZ289945B6 (cs) 2002-04-17
AU6991096A (en) 1997-04-01
DE69632405T2 (de) 2005-05-19
KR100457755B1 (ko) 2005-02-28
CA2228670C (fr) 2005-04-12
HK1041489A1 (en) 2002-07-12
SK285853B6 (sk) 2007-09-06
AR004195A1 (es) 1998-11-04
BG102312A (en) 1998-09-30
CZ294866B6 (cs) 2005-04-13
HUP9802930A1 (hu) 1999-04-28
CZ71798A3 (cs) 1998-07-15
SK29498A3 (en) 1998-12-02
HU227565B1 (en) 2011-08-29
NO312678B1 (no) 2002-06-17
KR19990044543A (ko) 1999-06-25
US5969161A (en) 1999-10-19
PL183652B1 (pl) 2002-06-28
EE9800065A (et) 1998-08-17
HK1016187A1 (en) 1999-10-29
MX9801859A (es) 1998-11-30
UA53628C2 (uk) 2003-02-17
WO1997010251A1 (fr) 1997-03-20
EA000575B1 (ru) 1999-12-29
CZ294865B6 (cs) 2005-04-13
ES2219698T3 (es) 2004-12-01
SI0854880T1 (en) 2004-12-31
HK1041489B (zh) 2006-09-08
SK285995B6 (sk) 2008-01-07
PL326274A1 (en) 1998-08-31
CA2228670A1 (fr) 1997-03-20
NO20021111D0 (no) 2002-03-06
IL123550A0 (en) 1998-10-30
TR199800438T1 (xx) 1998-05-21
NO981053D0 (no) 1998-03-10
DE69632405D1 (de) 2004-06-09
CN1319602A (zh) 2001-10-31
ATE266035T1 (de) 2004-05-15
CN1201462A (zh) 1998-12-09
CN1237069C (zh) 2006-01-18
AP9801210A0 (en) 1998-03-31
BG63822B1 (bg) 2003-02-28

Similar Documents

Publication Publication Date Title
ZA966837B (en) Derivatives of 5-0-desosaminyl 6-0-methyl erythronolide A, their preparation process and their use for the preparation of biologically-active products.
SI0676409T1 (en) Erythromycin derivatives, their process for preparation and their application as medicaments
AP9500744A0 (en) New erythromycin derivatives, their process and their use as medicaments
HUP9800725A3 (en) 4-benzoyl-pyrozol derivatives, process for their preparation and their use as herbicides
HUP9601652A1 (en) Piridyl-naphthalene derivatives, process for the preparation thereof, and intermediates thereof
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
AU5036999A (en) Epothilon derivatives, their preparation process, intermediate products and their pharmaceutical use
HUP9802552A3 (en) Piperazino derivatives process for their preparation, pharmaceuticals containing the same and their use
ZA971659B (en) Erythromycin derivatives, their preparation process and their use as medicaments.
HUP9600071A3 (en) Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9802320A3 (en) Macrolides, procedure of the preparation of macrolides, macrolides containing pharmaceutical products
HUP9800555A3 (en) 3,3-diphenylallylamine derivatives and process for their preparation
ZA966666B (en) Derivatives of 5-0-desosaminyl 6-0-methyl erythronolide A, their preparation process and their use in the preparation of biologically active products.
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
HRP960583B1 (en) New phenylamidine derivatives, a process for preparing the same and their use as medicaments
ZA969442B (en) Preparation process for phenylimidazolidine derivatives.
EP0846697A4 (en) PROCESS FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
ZA966128B (en) Noodle preparation process.
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
ZA961986B (en) Phosponomonoester nucleic acids, process for their preparation, and their use
EP0778278B1 (de) Alkoxyformoxysilane, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung